Cargando…
Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread
The havoc unleashed by COVID-19 pandemic has paved way for secondary ominous fungal infections like Mucormycosis. It is caused by a class of opportunistic pathogens from the order Mucorales. Fatality rates due to this contagious infection are extremely high. Numerous clinical manifestations result i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763841/ https://www.ncbi.nlm.nih.gov/pubmed/35058909 http://dx.doi.org/10.3389/fmicb.2021.794176 |
_version_ | 1784634039259365376 |
---|---|
author | Dogra, Shreya Arora, Akanksha Aggarwal, Aashni Passi, Gautam Sharma, Akanksha Singh, Gurpal Barnwal, Ravi P. |
author_facet | Dogra, Shreya Arora, Akanksha Aggarwal, Aashni Passi, Gautam Sharma, Akanksha Singh, Gurpal Barnwal, Ravi P. |
author_sort | Dogra, Shreya |
collection | PubMed |
description | The havoc unleashed by COVID-19 pandemic has paved way for secondary ominous fungal infections like Mucormycosis. It is caused by a class of opportunistic pathogens from the order Mucorales. Fatality rates due to this contagious infection are extremely high. Numerous clinical manifestations result in damage to multiple organs subject to the patient’s underlying condition. Lack of a proper detection method and reliable treatment has made the management of this infection troublesome. Several reports studying the behavior pattern of Mucorales inside the host by modulation of its defense mechanisms have helped in understanding the pathogenesis of this angio-invasive infection. Many recent advances in diagnosis and treatment of this fungal infection have not been much beneficial. Therefore, there is a need to foster more viable strategies. This article summarizes current and imminent approaches that could aid effective management of these secondary infections in these times of global pandemic. It is foreseen that the development of newer antifungal drugs, antimicrobial peptides, and nanotechnology-based approaches for drug delivery would help combat this infection and curb its spread. |
format | Online Article Text |
id | pubmed-8763841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87638412022-01-19 Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread Dogra, Shreya Arora, Akanksha Aggarwal, Aashni Passi, Gautam Sharma, Akanksha Singh, Gurpal Barnwal, Ravi P. Front Microbiol Microbiology The havoc unleashed by COVID-19 pandemic has paved way for secondary ominous fungal infections like Mucormycosis. It is caused by a class of opportunistic pathogens from the order Mucorales. Fatality rates due to this contagious infection are extremely high. Numerous clinical manifestations result in damage to multiple organs subject to the patient’s underlying condition. Lack of a proper detection method and reliable treatment has made the management of this infection troublesome. Several reports studying the behavior pattern of Mucorales inside the host by modulation of its defense mechanisms have helped in understanding the pathogenesis of this angio-invasive infection. Many recent advances in diagnosis and treatment of this fungal infection have not been much beneficial. Therefore, there is a need to foster more viable strategies. This article summarizes current and imminent approaches that could aid effective management of these secondary infections in these times of global pandemic. It is foreseen that the development of newer antifungal drugs, antimicrobial peptides, and nanotechnology-based approaches for drug delivery would help combat this infection and curb its spread. Frontiers Media S.A. 2022-01-04 /pmc/articles/PMC8763841/ /pubmed/35058909 http://dx.doi.org/10.3389/fmicb.2021.794176 Text en Copyright © 2022 Dogra, Arora, Aggarwal, Passi, Sharma, Singh and Barnwal. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Dogra, Shreya Arora, Akanksha Aggarwal, Aashni Passi, Gautam Sharma, Akanksha Singh, Gurpal Barnwal, Ravi P. Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread |
title | Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread |
title_full | Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread |
title_fullStr | Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread |
title_full_unstemmed | Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread |
title_short | Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread |
title_sort | mucormycosis amid covid-19 crisis: pathogenesis, diagnosis, and novel treatment strategies to combat the spread |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763841/ https://www.ncbi.nlm.nih.gov/pubmed/35058909 http://dx.doi.org/10.3389/fmicb.2021.794176 |
work_keys_str_mv | AT dograshreya mucormycosisamidcovid19crisispathogenesisdiagnosisandnoveltreatmentstrategiestocombatthespread AT aroraakanksha mucormycosisamidcovid19crisispathogenesisdiagnosisandnoveltreatmentstrategiestocombatthespread AT aggarwalaashni mucormycosisamidcovid19crisispathogenesisdiagnosisandnoveltreatmentstrategiestocombatthespread AT passigautam mucormycosisamidcovid19crisispathogenesisdiagnosisandnoveltreatmentstrategiestocombatthespread AT sharmaakanksha mucormycosisamidcovid19crisispathogenesisdiagnosisandnoveltreatmentstrategiestocombatthespread AT singhgurpal mucormycosisamidcovid19crisispathogenesisdiagnosisandnoveltreatmentstrategiestocombatthespread AT barnwalravip mucormycosisamidcovid19crisispathogenesisdiagnosisandnoveltreatmentstrategiestocombatthespread |